$RKLB

Clevenger Marvin Bradford sold $513K of RKLB

Clevenger Marvin Bradford (President, Rocket Lab USA, Inc) sold 3,500 shares of Rocket Lab Corp (RKLB) at $146.67 ($0.51M total) on 2026-05-28.

Original reporting
SEC EDGAR · Clevenger Marvin Bradford
Published Jun 1, 2026, 10:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 1, 2026, 10:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RKLB
Neutral
high confidence
Mentioned
$RKLB
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RKLBNeutralLow
01

Why it matters

Provides a discrete datapoint on insider selling (3,500 shares at ~$146.67) but no new business, financial, or regulatory development.

02

Market read

Traders may monitor insider activity as a sentiment input, but this filing alone is unlikely to drive a sustained repricing.

03

What to watch

Insider sales can be tax/estate-related and are not necessarily correlated with near-term performance; traders should weight this far below guidance, contract, launch, or financial updates.

Relevance 6/10Novelty 3/10Timing: Filed 2026-06-01 after the 2026-05-28 sale

Background

The article is an SEC EDGAR Form 4 insider transaction disclosure for Rocket Lab Corp.

Company-level read

Ticker impact

$RKLBNeutralHigh confidence
Context

SEC Form 4 shows Rocket Lab USA President Clevenger sold 3,500 shares in an open-market transaction on 2026-05-28.

Expected impact

Low near-term impact; any reaction is likely muted and short-lived unless paired with other disclosures/catalysts.

Evidence & confidence

The filing is a routine insider transaction with no stated link to company fundamentals; it provides a datapoint on selling behavior rather than new operational information.

Market effects

Minimal; insider selling in one issuer typically does not reset sector expectations without accompanying company-specific news.

None indicated.

None indicated.

Counterpoint

The sale may be routine diversification or liquidity-driven; without a 10b5-1 plan, it still doesn’t imply negative company prospects by itself.

Key entities

  • Rocket Lab Corp

    Subject of the SEC Form 4 insider sale by an officer (President, Rocket Lab USA, Inc).

  • Clevenger Marvin Bradford

    Officer (President, Rocket Lab USA, Inc) who sold 3,500 shares of RKLB.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$RKLBHigh

Rocket Lab (RKLB) Stock Drops After Neutron Rocket Launch Delay

Rocket Lab (RKLB) shares fell 7.9% during trading and 7.3% after-hours after delaying its Neutron rocket launch to 2027 due to manufacturing issues. The company's P/S ratio is 45.17, above historical and industry averages, reflecting high growth expectations. Insider selling totaled $683.3 million over the past year. Rocket Lab has a GF Score of 77/100, indicating strong financial health but weak profitability.

$RKLBMed

Rocket Lab pushes Neutron rocket's debut flight to 2027, shares fall

Rocket Lab announced a delay in the debut flight of its Neutron rocket to 2027, pushing back from the previously targeted fourth quarter of 2026. The news caused the company's shares to drop about 6% in extended trading. Neutron is a reusable medium-lift rocket aimed at competing for larger commercial and national-security missions. Recently, Rocket Lab secured a multi-year launch agreement for 20 missions with Tokyo-based Synspective.

$RKLBHigh

Why is Rocket Lab stock tumbling today?

Rocket Lab (RKLB) stock dropped 7.2% in after-hours trading after delaying its Neutron rocket launch to 2027 due to manufacturing issues. The company also faces insider-selling pressure and a challenging macro environment with rising Fed rate hike bets. The stock is down over 60% from its 52-week high.

$RKLBHigh

Rocket Lab Stock Stumbles Despite Big Space Ambitions

Rocket Lab USA (RKLB) shares fell 8% during and after trading due to CEO Peter Beck's planned stock sale, SpaceX funding concerns, and a delay in the Neutron rocket launch to 2027. Despite record Q2 revenue of $234M and a strong backlog, investors worry about integration risks and profitability. Analysts maintain a Strong Buy rating with a $104.44 price target.